Chiauranib, CAS [[1256349-48-0]]

Produktübersicht

• Artikelname: Chiauranib, CAS [[1256349-48-0]]
• Artikelnummer: MCE-HY-124526
• Hersteller Artikelnummer: HY-124526
• Alternativnummer: MCE-HY-124526-100MG,MCE-HY-124526-10MMX1ML,MCE-HY-124526-50MG,MCE-HY-124526-25MG,MCE-HY-124526-10MG,MCE-HY-124526-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Ibcasertib, CS2164

Produktbeschreibung

Chiauranib (CS2164) is an orally active multi-target inhibitor against tumor angiogenesis. Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRalpha and c-Kit), mitosis-related kinase Aurora B, and chronic inflammation-related kinase CSF-1R, with IC50 values ranging from 1-9 nM. Chiauranib has strongly anticancer effects[1].

Produkteigenschaften

• Molekulargewicht: 435.47
• Reinheit: 99.28
• CAS Nummer: [1256349-48-0]
• Formel: C27H21N3O3
• Target-Kategorie: Aurora Kinase,c-Fms,c-Kit,Mitosis,PDGFR,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound